HomeNUVA • BMV
add
NuVasive Ord Shs
Previous close
$1,079.09
Year range
$1,079.09 - $1,079.09
Market cap
2.08B USD
P/E ratio
-
Dividend yield
-
Market news
REG
1.70%
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 317.79M | 2.36% |
Operating expense | 200.53M | 0.65% |
Net income | 7.36M | 924.64% |
Net profit margin | 2.32 | 900.00% |
Earnings per share | 0.56 | 19.15% |
EBITDA | 60.70M | -2.00% |
Effective tax rate | 41.02% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 80.72M | -64.28% |
Total assets | 2.09B | -3.89% |
Total liabilities | 1.20B | -11.18% |
Total equity | 892.54M | — |
Shares outstanding | 52.45M | — |
Price to book | 63.40 | — |
Return on assets | 3.26% | — |
Return on capital | 3.77% | — |
Cash Flow
Net change in cash
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Net income | 7.36M | 924.64% |
Cash from operations | 36.52M | -40.67% |
Cash from investing | -40.09M | 1.06% |
Cash from financing | -96.80M | -3,289.49% |
Net change in cash | -100.48M | -586.05% |
Free cash flow | 3.25M | -83.84% |
About
NuVasive, Inc. is a medical devices company based in San Diego, California. Founded in 1997, it primarily develops medical devices and procedures for minimally invasive spine surgery.
NuVasive's products include software systems for surgical planning and monitoring, access instruments, and implantable hardware. They help treat degenerative disc disease, lumbar spinal stenosis, degenerative spondylolisthesis, cervical disc degeneration, early onset scoliosis, and limb length discrepancy.
In the United States and internationally, most of its products are marketed directly to doctors, hospitals, and other healthcare facilities. They focus on integrated systems for their surgeon partners.
On September 1, 2023, it was announced that NuVasive had completed its merger with Globus Medical. Wikipedia
CEO
Founded
1997
Headquarters
Website
Employees
3,000